Incidence and Survival of Thyroid Cancer in Children, Adolescents, and Young Adults in Denmark: A Nationwide Study from 1980 to 2014
- PMID: 29943676
- DOI: 10.1089/thy.2018.0067
Incidence and Survival of Thyroid Cancer in Children, Adolescents, and Young Adults in Denmark: A Nationwide Study from 1980 to 2014
Abstract
Background: Thyroid cancer constitutes a major and increasing proportion of head and neck cancers in children and adolescents. The purpose of this study was to determine the incidence and survival of thyroid cancer in Danish patients aged 0-24 years from 1980 to 2014.
Methods: Patients aged 0-24 years registered with primary thyroid cancer in the Danish Cancer Registry or the Danish Pathology Data Bank during 1980-2014 were included. Crude incidence rates and age-adjusted incidence rates (AAIR) per 100,000, average annual percent change (AAPC), and overall survival (OS) were evaluated in relation to sex, histopathological tumor type, age at diagnosis, and year of diagnosis.
Results: A total of 297 thyroid cancer patients (72% female, 72% papillary carcinoma) were identified. The AAIR per 100,000 increased significantly from 0.36 in 1980 to 0.97 in 2014, with an AAPC of 2.9%. There was no significant increase in incidence among children and adolescents (0-17 years). However, among young adults (18-24 years), a significant increase in incidence was observed (AAPC 3.7%). The incidence of thyroid cancer increased with age from 0.05 among infants aged 0 years to 1.73 among young adults aged 24 years. Female patients and papillary carcinoma showed significant increase in incidence (AAPC 3.3% and 3.2%), whereas male patients and other histopathological tumor types showed no change. The 15-year OS was 99%. The lowest 15-year OS was observed among patients with medullary carcinomas at 96%. There was no significant difference in OS between groups based on histopathological tumor type, and there was no significant change in OS over time.
Conclusion: In this nationwide study, no change in OS was observed, but a significant increase was seen in the incidence of thyroid cancer among young adults (aged 18-24 years), mainly attributed to an increase among females and patients with papillary carcinoma. No increase in incidence was seen among children and adolescents. These findings demonstrate the excellent prognosis for children and adolescents diagnosed with thyroid cancer.
Keywords: adolescents; children; incidence; survival; thyroid cancer; young adults.
Similar articles
-
Trends in thyroid cancer: Retrospective analysis of incidence and survival in Denmark 1980-2014.Cancer Epidemiol. 2018 Aug;55:81-87. doi: 10.1016/j.canep.2018.05.009. Epub 2018 May 28. Cancer Epidemiol. 2018. PMID: 29852396
-
Thyroid carcinoma in children, adolescents, and young adults in Brazil: A report from 11 population-based cancer registries.PLoS One. 2020 May 1;15(5):e0232416. doi: 10.1371/journal.pone.0232416. eCollection 2020. PLoS One. 2020. PMID: 32357198 Free PMC article.
-
Childhood thyroid cancer in England and Wales.Br J Cancer. 1995 Sep;72(3):777-83. doi: 10.1038/bjc.1995.410. Br J Cancer. 1995. PMID: 7669594 Free PMC article.
-
Thyroid Cancer: 20-Year Comparative Mortality and Survival Analysis of Six Thyroid Cancer Histologic Subtypes by Age, Sex, Race, Stage, Cohort Entry Time-Period and Disease Duration (SEER*Stat 8.3.2) A Systematic Review of 145,457 Cases for Diagnosis Years 1993-2013.J Insur Med. 2018 Jan;47(3):143-158. doi: 10.17849/insm-47-03-143-158.1. J Insur Med. 2018. PMID: 30192723
-
Are we really at the dawn of understanding sporadic pediatric thyroid carcinoma?Endocr Relat Cancer. 2015 Dec;22(6):R311-24. doi: 10.1530/ERC-15-0381. Epub 2015 Aug 25. Endocr Relat Cancer. 2015. PMID: 26307021 Review.
Cited by
-
Opposite Incidence Trends for Differentiated and Medullary Thyroid Cancer in Young Dutch Patients over a 30-Year Time Span.Cancers (Basel). 2021 Oct 12;13(20):5104. doi: 10.3390/cancers13205104. Cancers (Basel). 2021. PMID: 34680253 Free PMC article.
-
Selpercatinib prior to radioactive iodine for pediatric papillary thyroid carcinoma.J Pediatr Endocrinol Metab. 2024 Sep 3;37(11):1009-1014. doi: 10.1515/jpem-2024-0281. Print 2024 Nov 26. J Pediatr Endocrinol Metab. 2024. PMID: 39239989
-
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma.Eur Thyroid J. 2022 Nov 29;11(6):e220146. doi: 10.1530/ETJ-22-0146. Print 2022 Dec 1. Eur Thyroid J. 2022. PMID: 36228315 Free PMC article.
-
Incidence and Survival for Head and Neck Cancers in Estonia, 1996-2016: A Population-Based Study.Clin Epidemiol. 2021 Feb 24;13:149-159. doi: 10.2147/CLEP.S293929. eCollection 2021. Clin Epidemiol. 2021. PMID: 33658861 Free PMC article.
-
MicroRNA-643 promotes proliferation and inhibits apoptosis of papillary thyroid carcinoma by down-regulating the cytochrome P450 family member 11B1.Transl Cancer Res. 2020 Mar;9(3):1465-1475. doi: 10.21037/tcr.2020.01.43. Transl Cancer Res. 2020. PMID: 35117494 Free PMC article.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical